Amydis Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $6.5M
Latest Deal Amount
  • Investors
  • 3

Amydis General Information

Description

Operator of an ocular tracer biotechnology company intended to revolutionize the early detection and treatment of neurodegenerative diseases, as well as the clinical evaluation of novel therapeutics. The company develops novel, patent-protected small molecule ocular tracers, which enable direct visualization of retinal disease-related molecular changes (biomarkers) in the eye, enabling healthcare professionals to identify disorders that involve the presence of amyloid proteins for targeting the detection of early-stage Alzheimer's and other amyloid-associated diseases.

Contact Information

Website
www.amydis.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • 10210 Campus Point Drive
  • Suite 150
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Amydis Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Amydis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 10-Aug-2021 $6.5M Completed Generating Revenue
4. Grant 23-Sep-2019 00.00 Completed Generating Revenue
3. Early Stage VC 01-Jan-2017 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2016 Completed Generating Revenue
1. Accelerator/Incubator 02-Mar-2015 Completed Startup
To view Amydis’s complete valuation and funding history, request access »

Amydis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of an ocular tracer biotechnology company intended to revolutionize the early detection and treatment of neurod
Diagnostic Equipment
San Diego, CA
7 As of 2021
0000000000

00000000

na aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea
0000 000000000
New York, NY
00 As of 0000
0000
00.00 0000-00-00
00000000000 0000

000 0000

xercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
0000 000000000
Barcelona, Spain
00 As of 0000
0000
00000000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Amydis Competitors (6)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Volastra Venture Capital-Backed New York, NY 00 0000 00000000000 0000
000 000000000000 Venture Capital-Backed Barcelona, Spain 00 0000 00000000000 0000
0000000 000000 Venture Capital-Backed Stockholm, Sweden 0 000.00 0000000000 0 000.00
00 000000000000 Formerly VC-backed Durham, NC 000 00000 000000 - 000 00000
000000000 000000 Venture Capital-Backed Boston, MA 00 00000 0000000000 0 00000
To view Amydis’s complete competitors history, request access »

Amydis Patents

Amydis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2960723-A1 In vitro compositions comprising human sample and amyloid targeting agent Pending 12-Sep-2014 00000000000
AU-2015314767-A1 In vitro compositions comprising human sample and amyloid targeting agent Granted 12-Sep-2014 00000000000
AU-2015314767-B2 In vitro compositions comprising human sample and amyloid targeting agent Active 12-Sep-2014 00000000000
EP-3191107-A2 In vitro compositions comprising human sample and amyloid targeting agent Withdrawn 12-Sep-2014 00000000000
US-20170248616-A1 In vitro compositions comprising human sample and amyloid targeting agent Abandoned 12-Sep-2014 G01N33/6896 0
To view Amydis’s complete patent history, request access »

Amydis Executive Team (8)

Name Title Board Seat Contact Info
Stella Sarraf Ph.D Co-Founder, Chief Executive Officer & Board Member
Ron Newbold Ph.D Chief Business Officer
Jerry Yang Ph.D Co-Founder & Scientific Advisory Board
Masoud Mokhtarani MD Chief Medical Officer
You’re viewing 4 of 8 executive team members. Get the full list »

Amydis Board Members (7)

Name Representing Role Since
Christine Aylward Self Board Member 000 0000
Faith Charles JD Self Board Member 000 0000
Franz Hefti Ph.D Self Board Member 000 0000
James Khodabakhsh MD Amydis Board Member 000 0000
Stella Sarraf Ph.D Amydis Co-Founder, Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Amydis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Amydis Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
San Diego Venture Group Venture Capital Minority 000 0000 000000 0
Springboard Enterprises Accelerator/Incubator 000 0000 000000 0
Johnson & Johnson Innovation - JLABS Accelerator/Incubator 000 0000 000000 0
To view Amydis’s complete investors history, request access »